|
WO2011154012A1
|
|
Mini-tablets comprising porous adsorbent material
|
|
WO2011154013A1
|
|
Pharmaceutical composition comprising fenofibric acid
|
|
WO2011154009A1
|
|
Composition comprising an active principle in an amorphous form and a porous adsorbent material
|
|
US2011244031A1
|
|
Porous tablets as carriers for liquid formulations
|
|
KR20110033262A
|
|
Tacrolimus for improved treatment of transplant patients
|
|
WO2009080030A1
|
|
Treatment of autoimmune hepatitis with a once daily oral dosage form comprising tacrolimus
|
|
US2007190138A1
|
|
Stabilized atorvastatin
|
|
CN101365428A
|
|
Disintegrating loadable tablets
|
|
US2009011013A1
|
|
Tacrolimus Combination Products
|
|
US2007014846A1
|
|
Pharmaceutical compositions comprising fenofibrate and atorvastatin
|
|
EP1896075A2
|
|
Pharmaceutical compositions comprising tacrolimus and a cyp3a4 inhibitor
|
|
CA2604970A1
|
|
A tablet comprising a fibrate
|
|
AU2006222409A1
|
|
Pharmaceutical compositions comprising sirolimus and/or an analogue thereof
|
|
CN101115478A
|
|
A stable pharmaceutical composition comprising a fixed dose combination of fenofibrate and an HMG-CoA reductase inhibitor
|
|
WO2006037345A1
|
|
Pharmaceutical composition comprising fenofibrate and simvastatin
|
|
CA2582403A1
|
|
Pharmaceutical compositions comprising fenofibrate and atorvastatin
|
|
WO2006037348A1
|
|
Pharmaceutical compositions comprising fenofibrate and a statin
|
|
CA2572180A1
|
|
Porous tablets as carriers for liquid formulations
|
|
EP1691795A2
|
|
Pharmaceutical compositions comprising danazol
|
|
ZA200605290B
|
|
Pharmaceutical compositions comprising lercanidipine
|
